Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

Jianpixiaozhong particles and Wuse Dietotherapy

Low dose Radiotherapy

Mailed nicotine replacement therapy (NRT)

Medical therapy

Nicotine Replacement Therapy (Habitrol)

Nicotine Replacement therapy

Nicotine replacement therapy sampling

Nutritional therapy

Only conventional drug therapy

P2Y12 antagonist monotherapy

Physiotherapy

Postoperative radiotherapy

Prebiotic Fiber Supplement + loperamide hydrochloride capsule

Protocol-based management of perioperative antithrombotic therapy

Protocol-based management of perioperative antithrombotic therapy

Qingre Huashi Granules combined the modified dual therapy

Radiation therapy

Radiotherapy combined with TKI and Anti-PD-1 Antibody

Regional lymph node radiotherapy (RNI) including the axilla

Rehabilitation Therapy as part of Standard of Care (Control)

Stereotactic body radiotherapy (SBRT)

Steroid and Proton Pump Inhibitor Therapy

Surgery combined with Target-reduction intensity-modulated radiotherapy

Surgery-radiotherapy

Frequently asked questions